(Q37357342)

19 August 2017

1 reference

title

A review of current devices and a look at new technology: drug-eluting stents (English)

1 reference

19 August 2017

3

Frank D Kolodgie

1 reference

19 August 2017

2

Aloke V Finn

1 reference

19 August 2017

4

Renu Virmani

1 reference

19 August 2017

1

Gaku Nakazawa

1 reference

19 August 2017

language of work or name

1 reference

1 January 2009

1 reference

Expert Review of Medical Devices

19 August 2017

published in

1 reference

19 August 2017

volume

6

1 reference

19 August 2017

issue

1

1 reference

19 August 2017

page(s)

33-42

1 reference

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Stent thrombosis redux--the FDA perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Images in cardiovascular medicine. Sirolimus-eluting stent implanted in human coronary artery for 16 months: pathological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Vascular responses to drug eluting stents: importance of delayed healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Occupational allergies caused by latex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Toxicity of methyl methacrylate in dentistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Pathological analysis of local delivery of paclitaxel via a polymer-coated stent

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Overview of the 2007 Food and Drug Administration Circulatory System Devices Panel meeting on patent foramen ovale closure devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Four-year clinical follow-up after implantation of the endeavor zotarolimus-eluting stent: ENDEAVOR I, the first-in-human study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Endothelial cell recovery between comparator polymer-based drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Synthetic biodegradable polymers as orthopedic devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Taxanes: microtubule and centrosome targets, and cell cycle dependent mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Evaluation of four-year coronary artery response after sirolimus-eluting stent implantation using serial quantitative intravascular ultrasound and computer-assisted grayscale value analysis for plaque composition in event-free patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Paclitaxel enhances thrombin-induced endothelial tissue factor expression via c-Jun terminal NH2 kinase activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Rapamycin, but not FK-506, increases endothelial tissue factor expression: implications for drug-eluting stent design

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Antiproliferative agents alter vascular plasminogen activator inhibitor-1 expression: a potential prothrombotic mechanism of drug-eluting stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

BioMatrix Biolimus A9-eluting coronary stent: a next-generation drug-eluting stent for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Inflammation and restenosis: implications for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Overview of pharmacology and clinical trials program with the zotarolimus-eluting endeavor stent

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Randomized trial of a nonpolymer-based rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late lumen loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.1.33

21 January 2018

Identifiers

DOI

10.1586/17434440.6.1.33

1 reference

19 August 2017

1 reference